February 10, 2026- Siemens Healthineers and Northwestern Medicine have announced a multi-year strategic collaboration aimed at advancing imaging, theranostics and oncology innovation across the Chicago region. The partnership is designed to accelerate new approaches to diagnosis and treatment while improving the overall cancer-care experience for patients.
According to the joint announcement, the first phase of the alliance will focus on integrating advanced imaging technology, digital tools and clinical expertise to deliver faster diagnoses, more personalized therapies and streamlined care pathways. Leaders from both organizations say the collaboration could help establish a new standard for precision oncology and expand access to advanced cancer care closer to where patients live.
A central goal of the partnership is the creation of a global center of excellence in theranostics—an emerging field that combines radiopharmaceutical imaging and targeted treatment to personalize cancer care. Additional focus areas include improving patient-journey workflows, advancing interventional radiology techniques and using AI-enabled tools to optimize radiation oncology planning and delivery.
Officials noted that Siemens Healthineers and Northwestern Medicine have collaborated in research for more than two decades. This expanded alliance builds on that relationship with the aim of accelerating innovation and improving outcomes across the cancer-care continuum.